ELIZABETH FOGLE: Open Payments
NPI 1487424040 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 48 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $268 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $182 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| ABBVIE INC. | 5 | $87 |
| Lilly USA, LLC | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Exact Sciences Corporation | 3 | $61 |
| Amgen Inc. | 3 | $55 |
| Dexcom, Inc. | 2 | $42 |
| SHIELD THERAPEUTICS INC | 2 | $32 |
Products named: Auvelity, REXULTI, MOUNJARO, AIRSUPRA, Ozempic, EVENITY, Wegovy, Rybelsus.
Industry payments across NC — which companies pay providers there.
